Key result
HCMV infection in CHD is linked to higher inflammatory markers and worse clinical severity.
Why the study?
This study evaluated the impact of human cytomegalovirus infection on vascular inflammation and clinical characteristics in patients with coronary atherosclerotic heart disease.
Does human cytomegalovirus (HCMV) infection exacerbate vascular inflammation and clinical severity in patients with coronary atherosclerotic heart disease?
Observational (n=270)
Does human cytomegalovirus (HCMV) infection exacerbate vascular inflammation and clinical severity in patients with coronary atherosclerotic heart disease?
HCMV infection in patients with coronary atherosclerotic heart disease is associated with increased vascular inflammation and worse disease severity, suggesting a potential role for antiviral therapy.
Answers are grounded in this paper and cite their sources.
HCMV may exacerbate CAD inflammation; hypothesis-generating and should not yet change practice.
This study evaluated the impact of human cytomegalovirus (HCMV) infection on vascular inflammation and clinical characteristics in patients with coronary atherosclerotic heart disease (CHD). A total of 180 CHD patients with HCMV infection (research group) and 90 CHD patients without HCMV infection (control group) were enrolled. Serum levels of hs-CRP, TNF-α, IL-6, and Lp-PLA2 were measured, and clinical data were collected. The research group showed significantly higher inflammatory marker levels than controls (p < 0.05). Mean viral load was 4.58 ± 1.01 copies/mL, and high-load patients had higher marker levels than low-load patients (p < 0.05). Significant between-group differences were observed in CHD severity, number of diseased vessels, stenosis degree, cardiac function, angina grade, and carotid atherosclerosis (p < 0.05). HCMV viral load was positively correlated with all inflammatory markers and clinical severity indices (p < 0.05). These findings indicate that HCMV infection is associated with exacerbated vascular inflammation and worse CHD progression, suggesting the need for timely antiviral intervention.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted an observational in Coronary atherosclerotic heart disease (n=270). Human cytomegalovirus (HCMV) infection vs. No HCMV infection was evaluated on Vascular inflammation (hs-CRP, TNF-α, IL-6, Lp-PLA2) and clinical characteristics (p=<0.05). Human cytomegalovirus infection in patients with coronary atherosclerotic heart disease was associated with significantly higher inflammatory marker levels and worse clinical severity indices (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: